NC
DMTK

NinePointTwo Capital’s DermTech, Inc. Common Stock DMTK Stock Holding History

NinePointTwo Capital’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30,526
Closed -$448K – 276
2022
Q1 		$448K Buy
30,526
+15,567
+104% +$208K 0.12% 50
2021
Q4 		$236K Buy
+14,959
New +$359K 0.08% 138

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

NinePointTwo Capital's DMTK Position: Q2 2022 in Review

NinePointTwo Capital sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2022, closing a stake of 30,526 shares — an estimated $448K sold.

NinePointTwo Capital first reported a position in DMTK in Q4 2021 and held it in 2 quarters. The position peaked at $448K in Q1 2022. 134 funds tracked by Wall St. Rank hold DMTK as of Q2 2022.

  • NinePointTwo Capital reported no remaining DermTech, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • NinePointTwo Capital sold 30,526 DermTech, Inc. Common Stock shares in Q2 2022, an estimated $448K.
  • NinePointTwo Capital first reported a position in DermTech, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • NinePointTwo Capital's DermTech, Inc. Common Stock position peaked at $448K in Q1 2022.
  • 134 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2022.

Based on NinePointTwo Capital's 13F filing for Q2 2022, filed 15 Aug 2022.